StemiGen Therapeutics is a Singapore biotechnology company with the current focus on harnessing the regenerative properties of human stem cells and its derivatives for chronic wound healing and life enhancement. We aim to provide a cheaper and less painful treatment option than traditional approaches. In doing so, we hope to uplift the life of individuals.
Our founding team comprises of individuals, with extensive experiences in stem cell research, business and commercialisation, and healthcare, who are passionate in bringing scientific break-through to benefit patients.
We collaborate with local and overseas partner institutions in research and healthcare. Together with leading clinical advisors, we aim to propel StemiGen to the forefront of stem cell therapy with their critical expertise and experience on the development of our clinical pipelines.
To be the first Asian company on successful stem cell clinical trial to generate highest level of GMP grade cells for wound healing
We are committed to ensure the highest stringency in providing safe stem cell applications
To enhance the life of human with innovative stem cell applications